Table 4.
Subcutaneous Adipose Tissue mRNA Transcript Levels in Patients Treated With Aromatase Inhibitors and in Control Subjects
Patients (n = 20) | Control Subjects (n = 18) | P | |
---|---|---|---|
Steroid hormone synthesis and metabolism | |||
HSD11B1, 11βHSD1 | 0.91 ± 0.15 | 0.78 ± 0.10 | NSa |
AKR1C2, aldo-keto reductase 1C2 | 1.01 ± 0.20 | 0.80 ± 0.11 | NSa |
CYP19A1 aromatase | 0.66 ± 0.14 | 0.42 ± 0.09 | NSa |
Steroid hormone receptors | |||
AR, androgen receptor | 0.77 ± 0.06 | 0.71 ± 0.05 | NSa |
ESR1, estrogen receptor α | 0.74 ± 0.10 | 0.59 ± 0.07 | NSa |
ESR2, estrogen receptor β | 0.41 ± 0.03 | 0.42 ± 0.03 | NS |
Adipogenesis, lipogenesis, and lipolysis | |||
ACACA, acetyl CoA carboxylase | 0.76 ± 0.09 | 0.65 ± 0.11 | NS |
UCP2, uncoupling protein 2 | 0.44 ± 0.04 | 0.46 ± 0.03 | NSa |
FASN, fatty acid synthase | 0.65 ± 0.07 | 0.62 ± 0.07 | NS |
LIPE, hormone-sensitive lipase | 1.28 ± 0.17 | 0.99 ± 0.14 | NS |
PLIN2, perilipin 2 | 0.70 ± 0.07 | 0.55 ± 0.05 | NS |
LKB1, liver kinase B1 | 1.44 ± 0.19 | 0.98 ± 0.15 | 0.030a |
CTNNB1, β-catenin | 0.62 ± 0.04 | 0.45 ± 0.02 | 0.023 |
PNPLA2, adipose triglyceride lipase | 0.58 ± 0.07 | 0.62 ± 0.08 | NSa |
PPARG, peroxisome proliferator-activated receptor γ | 0.91 ± 0.11 | 0.68 ± 0.10 | NSa |
PPARGC1A, PGC-1α | 0.67 ± 0.08 | 0.58 ± 0.08 | NS |
Lipid and sterol metabolism | |||
CETP, cholesterol ester transfer protein | 0.62 ± 0.14 | 0.90 ± 0.24 | NSa |
LPL, lipoprotein lipase | 1.25 ± 0.07 | 1.08 ± 0.14 | NSa |
SREBF1, sterol regulatory element binding transcription factor 1 | 0.86 ± 0.10 | 0.70 ± 0.12 | NS |
SREBF2, sterol regulatory element binding transcription factor 2 | 0.76 ± | 0.64 ± | NSa |
Adipokines | |||
IL6, interleukin-6 | 0.87 ± 0.15 | 1.00 ± 0.20 | NSa |
LEP, leptin | 0.92 ± 0.10 | 0.55 ± 0.06 | 0.003a |
ADIPOQ, adiponectin | 1.28 ± 0.10 | 1.17 ± 0.06 | NSb |
Miscellaneous | |||
IGF1R, IGF-1 receptor | 0.73 ± 0.06 | 0.62 ± 0.04 | NS |
IGF1, insulin-like growth factor-1 | 0.67 ± 0.05 | 0.64 ± 0.05 | NS |
AGT, angiotensinogen | 0.86 ± 0.08 | 0.95 ± 0.14 | NS |
ADRA2A, α-2-adrenergic receptor | 0.95 ± 0.09 | 0.83 ± 0.11 | NSa |
ARDB1, β-1-adrenergic receptor | 0.74 ± 0.07 | 0.65 ± 0.05 | NSa |
Data are presented as mean ± SEM (relative to cyclophyllin).
Abbreviation: NS, not significant.
Compared with independent-samples Student t test (data log transformed where not normally distributed as determined by Kolmogorov-Smirnov test).
Independent-samples Mann-Whitney U test where transformation did not result in normally distributed data.